-
SynBioBeta3 years agoMycelium Magic: Crafting a Greener Future – with Eben Bayer
On this SynBioBeta podcast, John Cumbers talks with Eben Bayer, the CEO of Ecovative, a pioneering company at the forefront of developing sustainable materials using mycelium....
-
SynBioBeta3 years agoVenture Visions: Investing in the Future of Synthetic Biology – with Ursheet Parikh
Today, John Cumbers talks with Ursheet Parikh, a general partner at Mayfield Fund, an early-stage, global venture capital firm with a people-first philosophy and a 50-plus-year...
-
SynBioBeta3 years agoFrom Ideas to Reality: Synthetic Biology Comes of Age – with Jason Kelly
Today John Cumbers talks with Jason Kelly, Co-founder and CEO of Ginkgo Bioworks. Together they will discuss synthetic biology’s coming of age” and get Jason’s take...
Global Biotechnology & Pharmaceutical Markets7 hours ago
Ensuring safety and accountability in China’s biomedical translation system
Helixgate Featured19 hours ago
Blood centers can help biopharma scale cell and gene therapies
Helixgate Featured22 hours ago
Psychedelics at FDA, Mike Davis’ CDER and translating tRNAs — a BioCentury podcast
Fierce Biotech6 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
Endpoints News6 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized6 months ago
